KRAS and cancer: A recent research found that KRAS mutant colorectal cancer (CRC) cells deliver mutant KRAS to neutrophils via TEVs, inducing the recruitment of neutrophils and the secretion of IL‐8, eventually causing cancer deterioration.[148]  Also in CRC, Shang et al.